Skip to content
Smart Money

Pharmaceuticals

LIVEN Liven Pharma Limited

Latest results: FY2026 · Jun 2026

Last close · 16 Oct 2026

Rs 31.90 -0.06%

Valuation · at the close on 16 Oct 2026

Liven Pharma Limited (LIVEN) valuation

LIVEN has no positive earnings to compare its share price with, so P/E is not meaningful. The shares are priced at 3.66× book value (sector median 3.14×).

P/E · today
—
FY2026
5-yr average— Sector median12.5×
P/B · today
3.66×
FY2026
5-yr average— Sector median3.14×
EV/EBITDA · today
—
5-yr average— Sector median6.7×
Dividend yield · today
0.0%
FY2026
5-yr average0.0% Payers' median4.6%

Market value Rs 3.6 bn at Rs 31.90. Sector medians use the latest close of 14 Pharmaceuticals companies; P/E and P/B only where earnings / book value are positive; the yield median covers dividend payers only. Not investment advice.

Valuation history

At each fiscal year-end price.

LIVEN valuation history (annual) (Rs mn)
Rs mn FY2026 Jul 2025 – Jun 2026 FY2025 Jul 2024 – Jun 2025 FY2024 Jul 2023 – Jun 2024 FY2023 Jul 2022 – Jun 2023 FY2022 Jul 2021 – Jun 2022 FY2021 Jul 2020 – Jun 2021 FY2020 Jul 2019 – Jun 2020 FY2019 Jul 2018 – Jun 2019 FY2018 Jul 2017 – Jun 2018 FY2017 Jul 2016 – Jun 2017 FY2016 Jul 2015 – Jun 2016
Market capitalisation 4,603.0 6,042.0 110.4 185.5 152.2 303.1 133.2 75.7 67.9 84.6 60.6
Enterprise value 4,454.9 6,068.8 348.9 423.1 387.5 536.2 359.5 300.0 290.5 250.4 208.5
Share price (period end) Rs 40.72 55.17 7.74 13.00 10.66 21.24 9.34 5.30 4.76 5.93 4.25
Price to book 4.67× 9.53× — — — — — — — 5.23× 1.47×
Price to sales 42.80× 35.61× — — — — — — — — —
EV / Sales 42.10× 47.68× — — — — — — — — —
Dividend yield (gross) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Free cash flow yield (0.5%) (0.8%) — — — — — (2.4%) (7.1%) (6.0%) (2.2%)
Dividend yield — 5-year average 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — —

LIVEN valuation: frequently asked questions

What is LIVEN's book value per share?

Liven Pharma Limited's book value per share was Rs 8.72 at the end of FY2026. The shares trade at 3.66× book value.

Information only, not investment advice.